vitamin D binding protein precrusor (208-218) [Homo sapiens]/[Oryctolagus cuniculus]
(Synonyms: H2N-His-Leu-Ser-Leu-Leu-Thr-Thr-Leu-Ser-Asn-Arg-OH ) 目录号 : GP10019vitamin D binding protein precrusor
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Vitamin D-binding protein (DBP) is a multifunctional, highly expressed, polymorphic serum protein[1][2]. Since its identification in 1959, many important functions of Vitamin D binding protein have been discovered. These range from the transport of vitamin D metabolites to possible roles in the immune system and host defense[3]. The molecular weight range, time course of appearance, and effect of dietary strontium all suggested that the newly appearing protein( band C) might represent the calcium binding protein formed in response to vitamin D. Using chromatographically purified calcium binding protein from rat intestine, it was shown that this protein(band C) most probably is the calcium binding protein. The major contaminating protein in the final purification of rat calcium binding protein has also been identified on gels as the preexisting protein (band A), which is probably the precursor of the calcium binding protein.[4].
References:
[1] N.E. Cooke, J.G. Haddad, Vitamin D binding protein (Gc-globulin), Endocr. Rev., 10 (1989), pp. 294-307
[2] N.E. Cooke, J.G. Haddad, Vitamin D binding protein (Gc-globulin): update 1995, A. Negro-Vilar, D.D. Bikle (Eds.), Endocrine Reviews Monographs: 4. Hormonal Regulation of Bone Mineral Metabolism, The Endocrine Society (1995), pp. 125-128
[3] Peter White, Nancy Cooke, pThe Multifunctional Properties and Characteristics of Vitamin D-binding Proteinq,Volume 11, Issue 8, 1 October 2000, Pages 320-327.
[4] H. F. DeLuca , D. Drescher, Possible precursor of vitamin D-stimulated calcium binding protein in rats, Biochemistry, 1971, 10 (12), pp 2308-2312 , DOI: 10.1021/bi00788a020, Publication Date: June 1971.
Cas No. | SDF | ||
别名 | H2N-His-Leu-Ser-Leu-Leu-Thr-Thr-Leu-Ser-Asn-Arg-OH | ||
Canonical SMILES | NC(CC1=CN=CN1)C(NC(CC(C)C)C(NC(CO)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(C(C)O)C(NC(C(NC(CC(C)C)C(NC(CO)C(NC(CC(N)=O)C(NC(CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)C(O)C)=O)=O)=O)=O)=O)=O | ||
分子式 | C54H95N17O17 | 分子量 | 1254.44 |
溶解度 | ≥ 125.4mg/mL in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.7972 mL | 3.9858 mL | 7.9717 mL |
5 mM | 0.1594 mL | 0.7972 mL | 1.5943 mL |
10 mM | 0.0797 mL | 0.3986 mL | 0.7972 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。